Công ty Cổ phần Dược phẩm và Trang thiết bị Y tế

Bidiphar, officially known as the Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company, is a leading pharmaceutical manufacturer in Vietnam. Established in 1980, the company has transitioned from a regional distributor to a major producer of high-tech specialized medicines, particularly in the oncology sector. It holds the distinction of being the first domestic company in Vietnam to manufacture cancer treatment drugs, including cytotoxic and cytostatic injectables. Bidiphar operates several WHO-GMP certified facilities and is currently upgrading its infrastructure to meet EU-GMP standards for international expansion. Their diverse product portfolio includes antibiotics, cardiovascular medications, and vitamins, supported by a comprehensive distribution network that serves hospitals and pharmacies across Vietnam.